NewsModerna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 150% Posted on August 19, 2026 by budd87309@gmail.com The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone. budd87309@gmail.com DOJ cites Comey’s novel in urging judge not to toss ’86 47′ seashells threat to Trump case Fed officials saw need for rate hike if inflation doesn’t cool, minutes show
